Molecule intelOpportunity: ModerateEssential

Fluticasone

51 brands · 25 companies · product forms

ATC: D07AC17, R01AD08, R01AD12, R03BA05, R03BA09

Opportunity snapshot

Launch attractiveness
41
Market saturation
68
Price room
100
Regulatory risk
0
51
brands
25
companies
Rs 580.27
median price
22
price points
11.75x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 12%

Price room

Across observed sources and strengths
CheapestRs 200
MedianRs 580.27
Most expensiveRs 2,350
Spread11.75×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 11.75x across 22 trusted points (Rs 200.0-2350.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Fluticasone — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(32) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

25 canonical companies and 51 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 11.75x across 22 trusted points (Rs 200.0-2350.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.